{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T11:48:15Z","timestamp":1774698495354,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1007\/bf03190603","type":"journal-article","created":{"date-parts":[[2010,8,6]],"date-time":"2010-08-06T10:17:30Z","timestamp":1281089850000},"page":"225-230","source":"Crossref","is-referenced-by-count":6,"title":["Pharmacokinetics and dialysability of naltrexone in patients undergoing hemodialysis"],"prefix":"10.1007","volume":"29","author":[{"given":"Nicolas K.","family":"Kambia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Dine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Odou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salmane","family":"Bah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond","family":"Azar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Gressier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Th\u00e9r\u00e8se","family":"Dupin-Spriet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Luyckx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claude","family":"Brunet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF03190603_CR1","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/ndt\/14.4.834","volume":"14","author":"I.F. Schwartz","year":"1999","unstructured":"Schwartz I.F., Iaina A. (1999): Uraemic pruritus. Nephrol. Dial. Transplant., 14, 834\u2013839.","journal-title":"Nephrol. Dial. Transplant."},{"key":"BF03190603_CR2","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1093\/oxfordjournals.ndt.a027211","volume":"11","author":"T. Mettang","year":"1996","unstructured":"Mettang T., Thomas S., Kiefer T., Fischer F.P., Kuhlmann U., Wodarz R., Rettenmeier A.W. (1996): Uraemic pruritus and exposure to di(2-ethylhexyl) phthalate in haemodialysis patients. Nephrol. Dial. Transplant., 11, 2439\u20132443.","journal-title":"Nephrol. Dial. Transplant."},{"key":"BF03190603_CR3","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1056\/NEJM199204093261509","volume":"326","author":"M.W. Greaves","year":"1992","unstructured":"Greaves M.W. (1992): Itching-research has barely scratched the surface. N. Engl. J. Med., 326, 1016\u20131017.","journal-title":"N. Engl. J. Med."},{"key":"BF03190603_CR4","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/S0140-6736(96)04176-1","volume":"348","author":"G. Peer","year":"1996","unstructured":"Peer G., Kivity S., Agami O., Fireman E., Silverberg D., Blum M., Iaina A. (1996): Randomised crossover trial of naltrexone in uraemic pruritus. Lancet, 348, 1552\u20131554.","journal-title":"Lancet"},{"key":"BF03190603_CR5","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0190-9622(99)70117-9","volume":"41","author":"N.V. Bergasa","year":"1999","unstructured":"Bergasa N.V., Ailing D.W., Talbot T.L., Wells M.C., Jones A. (1999): Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: A controlled study. J. Am. Acad. Dermatol., 41, 431\u2013434.","journal-title":"J. Am. Acad. Dermatol."},{"key":"BF03190603_CR6","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1213\/00000539-199010000-00008","volume":"71","author":"T.K. Abboud","year":"1990","unstructured":"Abboud T.K., Lee K., Zhu S. (1990): Prophylactic oral naltrexone with intrathecal morphine for caesarian section: effects on adverses reactions and analgesia. Anesth. Analg., 71, 367\u2013370.","journal-title":"Anesth. Analg."},{"key":"BF03190603_CR7","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/gast.1997.v113.pm9322521","volume":"113","author":"F.H.J. Wolfhagen","year":"1997","unstructured":"Wolfhagen F.H.J., Sternier E., Hop W.C.J., Vitale G., Bertolotti M., Van Buuren H.R. (1997): Oral naltrexone treatment for cholestatic pruritus: A double-blind, placebo-controlled study. Gastroenterology, 113, 1264\u20131269.","journal-title":"Gastroenterology"},{"key":"BF03190603_CR8","first-page":"533","volume":"41","author":"D. Metze","year":"1999","unstructured":"Metze D., Reimann S., Beissert S., Luger T. (1999): Efficacy and safety of naltrexone, an oral opiate receptor antagonist in the treatment of pruritus in internal and dermatological diseases. J. Am. Acad. Dermatol., 41, 533\u2013539.","journal-title":"J. Am. Acad. Dermatol."},{"key":"BF03190603_CR9","first-page":"386","volume":"317","author":"F. Stockenhuber","year":"1987","unstructured":"Stockenhuber F., Sunder-Plassmann G., Balcke P. (1987): Increased plasma histamine levels in chronic renal failure. N. Engl. J. Med., 317, 386\u2013390.","journal-title":"N. Engl. J. Med."},{"key":"BF03190603_CR10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000186826","volume":"61","author":"N. Dimkovic","year":"1992","unstructured":"Dimkovic N., Djukanovic L., Radmilovic A., Bojic P., Juloski T. (1992): Uraemic pruritus and skin mast cells. Nephron, 61, 5\u20139.","journal-title":"Nephron"},{"key":"BF03190603_CR11","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1001\/jama.1992.03490230089034","volume":"268","author":"E.A. Jones","year":"1992","unstructured":"Jones E.A., Bergasa N.V. (1992): The pruritus of cholestasis and the opioid system. J. Am. Med. Assoc., 268, 3359\u20133362.","journal-title":"J. Am. Med. Assoc."},{"key":"BF03190603_CR12","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/0016-5085(92)90857-U","volume":"103","author":"M.G. Swain","year":"1992","unstructured":"Swain M.G., Rothman R.B., Xu H., Vergalla J., Bergasa N.V., Jones E.A. (1992): Endogenous opioids accumulate in plasma in a rat model of acute cholestasis. Gastroenterology, 103, 630\u2013635.","journal-title":"Gastroenterology"},{"key":"BF03190603_CR13","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s000110050211","volume":"46","author":"S. Kivity","year":"1997","unstructured":"Kivity S., Fireman E., Schwanz Y., Peer G., Agami O., Iaina A. (1997): The effect of naloxone on basophil histamine release from dialyzed patients. Inflamm. Res., 46, 404\u2013406.","journal-title":"Inflamm. Res."},{"key":"BF03190603_CR14","first-page":"1022","volume":"91","author":"K.L. Carson","year":"1996","unstructured":"Carson K.L., Tran T.T., Cotton P., Sharara A.I., Hunt C.M. (1996): Pilot study of the use of naltrexone to treat the severe pruritus of cholestasic liver disease. Am. J. Gastroenterol., 91, 1022\u20131023.","journal-title":"Am. J. Gastroenterol."},{"key":"BF03190603_CR15","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0376-8716(98)00098-2","volume":"52","author":"A. Ferrari","year":"1998","unstructured":"Ferrari A., Bertolotti M., Dell\u2019Utri A., Avico U., Sternieri E. (1998): Serum time- course of naltrexone and 6-\u03b2 naltrexol level during long term treatment in drug addict. Drug and Alcohol Depend., 52, 211\u2013220.","journal-title":"Drug and Alcohol Depend."},{"key":"BF03190603_CR16","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/1099-0801(200005)14:3<151::AID-BMC941>3.0.CO;2-E","volume":"14","author":"K. Kambia","year":"2000","unstructured":"Kambia K., Bah S., Dine T., Azar R., Odou P., Gressier B., Luyckx M., Ballester L., Cazin M., Cazin J.C. (2000): High-performance liquid chromatographic determination of naltrexone in plasma of hemodialysis patients. Biomed. Chromatogr., 14, 151\u2013155.","journal-title":"Biomed. Chromatogr."},{"key":"BF03190603_CR17","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/135562102200120442","volume":"7","author":"S.J. Porter","year":"2002","unstructured":"Porter S.J., Somogyi A.A., White J.M. (2002): In vivo and in vitro potency studies of 6-\u03b2 naltrexol, the major human metabolite of naltrexone, Addict Biol., 7, 219\u2013225.","journal-title":"Addict Biol."},{"key":"BF03190603_CR18","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2165\/00003088-198409010-00003","volume":"9","author":"C.S. Lee","year":"1984","unstructured":"Lee C.S., Marbury T.C. (1984): Drug therapy in patients undergoing haemodialysis: Clinical pharmacokinetic considerations. Clin. Pharmacokinet., 9, 42\u201366.","journal-title":"Clin. Pharmacokinet."},{"key":"BF03190603_CR19","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2125.1985.tb05049.x","volume":"20","author":"H. Martre","year":"1985","unstructured":"Martre H., Sari R., Tabouret A.M., Jacobs C., Singlas E.(1985): Haemodialysis does not affect the pharmacokinetics of nifedipine. British J. Clin. Pharmacol., 20, 155\u2013158.","journal-title":"British J. Clin. Pharmacol."},{"key":"BF03190603_CR20","first-page":"529","volume":"42","author":"E. Singlas","year":"1987","unstructured":"Singlas E., Lebelle A.V. (1987): Evaluation of drug dialysability. Therapie, 42, 529\u2013540.","journal-title":"Therapie"},{"key":"BF03190603_CR21","unstructured":"Gotch F. Hemodialysis: technical and kinetic considerations, in: C. Brenner, P. Rector (Eds), The kidney, 2ndedn, 1672\u20131704."},{"key":"BF03190603_CR22","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/ndt\/16.9.1953","volume":"16","author":"P. Odou","year":"2001","unstructured":"Odou P., Azar R., Luyckx M., Brunet C., Dine T. (2001): A hypothesis for endogenous opioid peptides in uraemic pruritus: role of enkephalin. Nephrol. Dial. Transplant., 16, 1953\u20131954.","journal-title":"Nephrol. Dial. Transplant."},{"key":"BF03190603_CR23","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/clinchem\/27.2.223","volume":"27","author":"F.A.J. Muskiet","year":"1981","unstructured":"Muskiet F.A.J., Stratingh M.C., Stob G.J., Wolthers B.G. (1981): Simultaneous determination of the four major catecholamine metabolites and estimation of a serotonin metaolite in urine by capillary gas chromatography of their TBDMS derivatives. Clin. Chem., 27, 223\u2013227.","journal-title":"Clin. Chem."}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03190603.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03190603\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03190603","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T02:50:01Z","timestamp":1591757401000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03190603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["BF03190603"],"URL":"https:\/\/doi.org\/10.1007\/bf03190603","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"value":"0378-7966","type":"print"},{"value":"2107-0180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}